You just read:

Regenera Pharma Enrolls First Patient in US Phase 3 Study of RPh201 in NAION, Advances Phase 2 Study in Alzheimer's Disease in Canada

News provided by

Regenera Pharma

Aug 02, 2018, 08:00 ET